Filing Overview
Jin Medical International Ltd. filed a Form 6-K for April 2024, dated April 12, 2024. The filing addresses the resignation of its former independent registered public accounting firm, DNTW Toronto LLP (DNTW), and a related unresolved disagreement concerning audit procedures for the September 30, 2023 financial statements.
Business Context and Reporting Period
The Company is a foreign private issuer headquartered in Changzhou, Jiangsu Province, China, and files annual reports on Form 20-F. The reported matter relates primarily to DNTW’s engagement from September 23, 2023 through February 2024 and the audit of the Company’s September 30, 2023 financial statements.
Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial metrics.
Material Changes and Unusual Items
- DNTW issued a letter in March 2024 stating that an unresolved disagreement existed regarding the scope of audit procedures needed to complete its work and issue an opinion on the September 30, 2023 financial statements.
- DNTW stated that the unresolved disagreement impaired its independence under applicable professional standards and resulted in its resignation as the Company’s auditor.
- The parties also disagreed on the effective resignation date: DNTW considered it February 25, 2024, while the Company considered it February 26, 2024.
- The Company stated that the disagreement primarily concerned the time required to complete certain audit procedures. The Company’s board, audit committee, and management attempted to resolve the matter with DNTW but did not reach consensus.
- On March 1, 2024, the Company authorized DNTW to respond fully to inquiries from the successor accountant regarding the disagreement.
Outlook, Risks, and Contingencies
The filing does not provide financial guidance or an operating outlook. The auditor resignation and unresolved audit-procedure disagreement may create risks relating to completion of the September 30, 2023 audit, the timing or form of the related financial statements, and potential additional audit work. The filing does not state whether the successor accountant has completed its procedures or whether any audit opinion has been issued.
Key Facts for Investors to Verify
- Whether a successor auditor has been formally appointed and the status of the September 30, 2023 audit.
- The precise scope of the disputed audit procedures and whether they resulted in any adjustments, qualifications, or delays.
- The effective date and regulatory characterization of DNTW’s resignation.
- Whether subsequent filings disclose any impact on the Company’s financial statements, internal controls, liquidity, or reporting deadlines.
- The contents of Exhibit 16.1, DNTW’s letter dated April 12, 2024.